​

Edesa Biotech Ownership | Who Owns Edesa Biotech?

OverviewFinancialsChart

Edesa Biotech Ownership Summary

Edesa Biotech is owned by 4.08% institutional investors, 15.04% insiders, and 80.88% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 10.38% of EDSA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.85% of its assets in Edesa Biotech shares.

EDSA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEdesa Biotech4.08%15.04%80.88%
SectorHealthcare Stocks 50.59%12.40%37.01%
IndustryBiotech Stocks 49.10%12.14%38.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Velan capital investment management lp827.50K10.38%$4.33M
Rubric capital management lp687.50K8.62%$3.60M
Perceptive advisors563.24K7.06%$2.95M
Jane street group115.72K1.45%$605.22K
Geode capital management77.05K0.97%$403.02K
Vanguard group37.60K0.53%$54.52K
Vanguard fiduciary trust38.45K0.48%$201.07K
State street37.98K0.48%$198.63K
Stonepine capital management30.00K0.38%$156.90K
Blackrock funding, inc. /de27.71K0.35%$144.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp827.50K2.71%$4.33M
Stonepine capital management30.00K0.06%$156.90K
Perceptive advisors563.24K0.06%$2.95M
Rubric capital management lp687.50K0.04%$3.60M
Sbi securities3.50K0.00%$18.32K
Scotia capital15.84K0.00%$82.86K
Tower research capital llc (trc)507.000.00%$2.65K
Vanguard fiduciary trust38.45K0.00%$201.07K
Jane street group115.72K0.00%$605.22K
Cibc world market---

Top Buyers

HolderShares% AssetsChange
Perceptive advisors563.24K0.06%563.24K
Velan capital investment management lp827.50K2.71%140.00K
Jane street group115.72K0.00%115.72K
Vanguard fiduciary trust38.45K0.00%38.45K
Geode capital management77.05K-30.52K

Top Sellers

HolderShares% AssetsChange
Stonepine capital management30.00K0.06%-657.50K
Nantahala capital management---625.00K
Drw securities---134.22K
Diadema partners lp---54.02K
Citadel advisors---53.63K

New Positions

HolderShares% AssetsChangeValue
Perceptive advisors563.24K0.06%563.24K$2.95M
Jane street group115.72K0.00%115.72K$605.22K
Vanguard fiduciary trust38.45K0.00%38.45K$201.07K
Blackrock funding, inc. /de27.71K-27.71K$144.92K
Scotia capital15.84K0.00%15.84K$82.86K

Sold Out

HolderChange
Dogwood wealth management-1.00
Barclays-6.00
Raymond james financial-29.00
Fifth third bancorp-100.00
Citigroup-487.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202614-33.33%325,327-89.34%40.28%10---100.00%
Dec 31, 202515-34.78%2,928,4311.80%412.47%5-44.44%2-33.33%
Sep 30, 20252215.79%2,876,70836.46%402.59%1025.00%350.00%
Jun 30, 2025195.56%2,108,116-25.30%391.40%8-2-33.33%
Mar 31, 20251812.50%2,822,2061260.01%53138.22%833.33%350.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr81.84K0.85%-
Fidelity Extended Market Index37.67K0.39%2.69K
Blackrock Extended Mkt Fund CF27.26K0.28%-
Extended Equity Market Fund K23.21K0.28%23.21K
BlackRock Extended Equity Market Fund K23.17K0.24%-45.00
Fidelity Total Market Index13.54K0.14%-
DFA US Micro Cap I7.91K0.11%-
Spartan Extended Market Index Pool F9.72K0.10%50.00
Fidelity Series Total Market Index9.60K0.10%-
DFA US Core Equity 2 I3.42K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 26, 2026Brooks Michael J PresidentBuy$3.14K
Mar 05, 2026Nijhawan Pardeep Chief Executive OfficerBuy$39.00K
Mar 04, 2026Nijhawan Pardeep Chief Executive OfficerBuy$42.56K
Mar 03, 2026Nijhawan Pardeep Chief Executive OfficerBuy$36.30K
Mar 02, 2026Nijhawan Pardeep Chief Executive OfficerBuy$2.28K

Insider Transactions Trends

DateBuySell
2026 Q3--
2026 Q2--
2026 Q18-
2025 Q4--
2025 Q3--

EDSA Ownership FAQ

Who Owns Edesa Biotech?

Edesa Biotech shareholders are primarily institutional investors at 4.08%, followed by 15.04% insiders and 80.88% retail investors. The average institutional ownership in Edesa Biotech's industry, Biotech Stocks , is 49.10%, which Edesa Biotech falls below.

Who owns the most shares of Edesa Biotech?

Edesa Biotech’s largest shareholders are Velan capital investment management lp (827.5K shares, 10.38%), Rubric capital management lp (687.5K shares, 8.62%), and Perceptive advisors (563.24K shares, 7.06%). Together, they hold 26.07% of Edesa Biotech’s total shares outstanding.

Does Blackrock own Edesa Biotech?

BlackRock is not among the top 10 institutional shareholders of Edesa Biotech.

Who is Edesa Biotech’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Edesa Biotech’s biggest shareholder by percentage of total assets invested, with 2.71% of its assets in 827.5K Edesa Biotech shares, valued at 4.33M$.

Who is the top mutual fund holder of Edesa Biotech shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Edesa Biotech shares, with 0.85% of its total shares outstanding invested in 81.84K Edesa Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools